期刊
CELL DEATH DISCOVERY
卷 8, 期 1, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41420-022-00820-0
关键词
-
类别
资金
- National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2017R1A2B3007224, 2019R1A2C2004052, 2020R1A4A4079494]
- National Research Foundation of Korea - Ministry of Science and ICT [2017H1D3A1A02054608]
- National Research Foundation of Korea [2019R1A2C2004052, 2020R1A4A4079494, 2017H1D3A1A02054608, 2017R1A2B3007224] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
The deubiquitinating enzyme USP15 and its close paralog USP4 regulate the alternative splicing of SRSF1, promoting lung cancer cell proliferation. The depletion of USP15 and USP4 leads to impairment of SRSF1 splicing, resulting in an alternative isoform SRSF1-3. The increased expression of USP15 contributes to the development of lung adenocarcinoma and is associated with lower disease-specific survival in patients.
The deubiquitinating enzyme USP15 is implicated in several human cancers by regulating different cellular processes, including splicing regulation. However, the underlying molecular mechanisms of its functional relevance and the successive roles in enhanced tumorigenesis remain ambiguous. Here, we found that USP15 and its close paralog USP4 are overexpressed and facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1. Depletion of USP15 and USP4 impair SRSF1 splicing characterized by the replacement of exon 4 with non-coding intron sequences retained at its C-terminus, resulting in an alternative isoform SRSF1-3. We observed an increased endogenous expression of SRSF1 in lung cancer cells as well, and its overexpression significantly enhanced cancer cell phenotype and rescued the depletion effect of USP15 and USP4. However, the alternatively spliced isoform SRSF1-3 was deficient in such aspects for its premature degradation through nonsense-mediated mRNA decay. The increased USP15 expression contributes to the lung adenocarcinoma (LUAD) development and shows significantly lower disease-specific survival of patients with USP15 alteration. In short, we identified USP15 and USP4 as key regulators of SRSF1 alternative splicing with altered functions, which may represent the novel prognostic biomarker as well as a potential target for LUAD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据